CoChat

CXCR3 blockade inhibits T‐cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease

Open access
Sporici, Romeo, Issekutz, Thomas B. · 2010 · European Journal of Immunology
Cited by 86

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Autoreactive T‐cell infiltration into the CNS is critical in MS and EAE. The chemokine receptor CXCR3 and its ligands are implicated in MS and mouse EAE, but the contribution of CXCR3 to T‐cell migration into the inflamed CNS remains controversial. During active disease in a rat EAE model, blood T‐cell, spleen T‐cell and T lymphoblast migration into the CNS was inhibited by a CXCR3 blocking mAb by, 30–70%, ∼75% and 50–80%, respectively. However, CXCR3 blockade after active immunization did not inhibit EAE, did not alter total T‐cell accumulation in the CNS and did not affect Treg accumulation or the presence of cells producing IFN‐γ or IL‐17. Conversely, CXCR3 blockade during EAE induced by adoptive transfer of myelin basic protein‐activated T cells delayed disease onset, shortened its duration and reduced disease severity. Moreover, CXCR3 blockade inhibited leukocyte infiltration of the CNS>95%, virtually abolishing infiltration of transferred T cells. Thus, CXCR3 plays a major role in T‐cell migration to the CNS and can be critical for encephalitogenic T‐cell migration into the CNS to induce disease, but CXCR3‐independent recruitment can also produce EAE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.200939975

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 86

Metadata

Authors
Sporici, R., & Issekutz, T. B.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2010-09
Volume
40
Issue
10
Pages
2751-2761
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2026992198
Cited by
86
References
2
FWCI
2.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.